PharmaBlock Sciences Nanjing Inc
SZSE:300725
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PharmaBlock Sciences Nanjing Inc
SZSE:300725
|
CN |
|
G
|
GIC Housing Finance Ltd
NSE:GICHSGFIN
|
IN |
|
K
|
Koninklijke Philips NV
MIL:PHIA
|
NL |
|
Khaitan (India) Ltd
NSE:KHAITANLTD
|
IN |
|
B
|
Bersama Mencapai Puncak PT Tbk
IDX:BAIK
|
ID |
|
Torq Resources Inc
XTSX:TORQ
|
CA |
|
A
|
Activision Blizzard Inc
LSE:0H8X
|
US |
|
Jiangsu Huaxin New Material Co Ltd
SZSE:300717
|
CN |
|
IMAX China Holding Inc
HKEX:1970
|
CN |
|
C
|
CAB Cakaran Corporation Bhd
KLSE:CARLSBG
|
MY |
|
Europap Tezol Kagit Sanayi Ve Ticaret AS
IST:TEZOL.E
|
TR |
|
H
|
Hainan Haiyao Co Ltd
SZSE:000566
|
CN |
Bankruptcy Probability
PharmaBlock Sciences Nanjing Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PharmaBlock Sciences Nanjing Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
PharmaBlock Sciences Nanjing Inc
SZSE:300725
|
8B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PharmaBlock Sciences Nanjing Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PharmaBlock Sciences Nanjing Inc has total debt of 103m CNY. This includes both short-term (100m CNY) and long-term (3m CNY) debt.
You can find a full breakdown on its Balance Sheet.
